{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:01:18Z","timestamp":1787068878850,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thespinejournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Spine Journal"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.spinee.2016.06.007","type":"journal-article","created":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T04:17:46Z","timestamp":1466655466000},"page":"1208-1213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["RhBMP-2-induced radiculitis in patients undergoing transforaminal lumbar interbody fusion: relationship to dose"],"prefix":"10.1016","volume":"16","author":[{"given":"Alan T.","family":"Villavicencio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigita","family":"Burneikiene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.spinee.2016.06.007_bib0010","series-title":"NASS coverage policy recommendations. Recombinant human bone morphogenetic protein (rhBMP-2)","author":"North American Spine Society","year":"2014"},{"key":"10.1016\/j.spinee.2016.06.007_bib0015","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/01.bsd.0000211231.83716.4b","article-title":"Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2)","volume":"19","author":"McClellan","year":"2006","journal-title":"J Spinal Disord Tech"},{"key":"10.1016\/j.spinee.2016.06.007_bib0020","doi-asserted-by":"crossref","first-page":"E1020","DOI":"10.1097\/BRS.0b013e3182982f8e","article-title":"Complications associated with the use of the recombinant human bone morphogenetic proteins for posterior interbody fusions of the lumbar spine","volume":"38","author":"Chrastil","year":"2013","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2016.06.007_bib0025","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1097\/BRS.0b013e31815b7596","article-title":"Heterotopic bone formation with the use of rhBMP2 in posterior minimal access interbody fusion: a CT analysis","volume":"32","author":"Joseph","year":"2007","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2016.06.007_bib0030","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.spinee.2009.04.004","article-title":"Complications associated with single-level transforaminal lumbar interbody fusion","volume":"9","author":"Rihn","year":"2009","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2016.06.007_bib0035","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jama.2009.956","article-title":"Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures","volume":"302","author":"Cahill","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.spinee.2016.06.007_bib0040","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.spinee.2007.06.014","article-title":"Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF\/TLIF use of bone morphogenetic protein-2 (BMP-2)","volume":"8","author":"Wong","year":"2008","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2016.06.007_bib0045","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.spinee.2004.03.025","article-title":"Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages","volume":"4","author":"Haid","year":"2004","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2016.06.007_bib0050","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/BRS.0b013e3182880298","article-title":"Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease\u2013part 2: BMP dosage-related complications and long-term outcomes in 509 patients","volume":"38","author":"Crandall","year":"2013","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2016.06.007_bib0055","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/01.brs.0000201424.27509.72","article-title":"Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion","volume":"31","author":"Shields","year":"2006","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2016.06.007_bib0060","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3171\/SPI\/2008\/8\/6\/529","article-title":"The safety and efficacy of anterior cervical discectomy and fusion with polyetheretherketone spacer and recombinant human bone morphogenetic protein-2: a review of 200 patients","volume":"8","author":"Tumialan","year":"2008","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.spinee.2016.06.007_bib0065","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.2106\/JBJS.L.01730","article-title":"High-dose rhBMP-2 for adults: major and minor complications: a study of 502 spine cases","volume":"95","author":"Mesfin","year":"2013","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.spinee.2016.06.007_bib0070","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/BRS.0000000000000104","article-title":"Does recombinant human bone morphogenetic protein-2 use in adult spinal deformity increase complications and are complications associated with location of rhBMP-2 use? A prospective, multicenter study of 279 consecutive patients","volume":"39","author":"Bess","year":"2014","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2016.06.007_bib0075","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/BRS.0000000000000004","article-title":"Complications of spinal fusion with utilization of bone morphogenetic protein: a systematic review of the literature","volume":"39","author":"Singh","year":"2014","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2016.06.007_bib0080","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1097\/BRS.0000000000000045","article-title":"Comparison of TLIF with rhBMP-2 versus no TLIF and higher posterolateral rhBMP-2 dose at L5-S1 for long fusions to the sacrum with sacropelvic fixation in patients with primary adult deformity","volume":"38","author":"Rahman","year":"2013","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2016.06.007_bib0085","series-title":"Summary of Safety and Effective Data premarket approval application P000058. Rockville, MD","year":"2002"},{"key":"10.1016\/j.spinee.2016.06.007_bib0090","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.2106\/JBJS.H.00200","article-title":"Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis","volume":"91","author":"Dimar","year":"2009","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.spinee.2016.06.007_bib0095","author":"Food and Drug Administration (FDA)"},{"key":"10.1016\/j.spinee.2016.06.007_bib0100","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.spinee.2010.06.020","article-title":"Histopathologic inflammatory response induced by recombinant bone morphogenetic protein-2 causing radiculopathy after transforaminal lumbar interbody fusion","volume":"10","author":"Muchow","year":"2010","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2016.06.007_bib0105","doi-asserted-by":"crossref","first-page":"E277","DOI":"10.1097\/BSD.0b013e318287f2e2","article-title":"Adverse events with the use of rhBMP-2 in thoracolumbar and lumbar spine fusions: a 9-year institutional analysis","volume":"28","author":"Lubelski","year":"2015","journal-title":"J Spinal Disord Tech"},{"key":"10.1016\/j.spinee.2016.06.007_bib0110","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s00586-010-1494-7","article-title":"Perioperative complications with rhBMP-2 in transforaminal lumbar interbody fusion","volume":"20","author":"Owens","year":"2011","journal-title":"Eur Spine J"},{"key":"10.1016\/j.spinee.2016.06.007_bib0115","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1097\/BRS.0b013e3181a396a1","article-title":"Recombinant human bone morphogenetic protein-2-induced radiculitis in elective minimally invasive transforaminal lumbar interbody fusions: a series review","volume":"34","author":"Mindea","year":"2009","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2016.06.007_bib0120","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/s00586-009-1046-1","article-title":"The use of RhBMP-2 in single-level transforaminal lumbar interbody fusion: a clinical and radiographic analysis","volume":"18","author":"Rihn","year":"2009","journal-title":"Eur Spine J"},{"key":"10.1016\/j.spinee.2016.06.007_bib0125","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3171\/spi.2005.3.6.0436","article-title":"Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein-2","volume":"3","author":"Villavicencio","year":"2005","journal-title":"J Neurosurg Spine"},{"issue":"Suppl. 9","key":"10.1016\/j.spinee.2016.06.007_bib0130","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1097\/BRS.0b013e3181d81ef2","article-title":"Complications related to osteobiologics use in spine surgery: a systematic review","volume":"35","author":"Mroz","year":"2010","journal-title":"Spine"},{"key":"10.1016\/j.spinee.2016.06.007_bib0135","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s00586-011-2113-y","article-title":"RhBMP-2 use in lumbar fusion surgery is associated with transient immediate post-operative leg pain","volume":"21","author":"Rowan","year":"2012","journal-title":"Eur Spine J"},{"key":"10.1016\/j.spinee.2016.06.007_bib0140","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/j.spinee.2007.07.015","article-title":"BMP-2 causes increased postoperative radiculitis following TLIF","author":"Sanfilippo","year":"2007","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2016.06.007_bib0145","series-title":"Early complications associated with BMP in lumbar interbody fusions. Spine Society of Australia, Annual Scientific Meeting","author":"Licina","year":"2008"},{"key":"10.1016\/j.spinee.2016.06.007_bib0150","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.spinee.2011.05.002","article-title":"Bone morphogenetic protein-2 and spinal arthrodesis: the basic science perspective on protein interaction with the nervous system","volume":"11","author":"Dmitriev","year":"2011","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2016.06.007_bib0155","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.spinee.2010.07.005","article-title":"Promoting fusion in minimally invasive lumbar interbody stabilization with low-dose bone morphogenic protein-2\u2013but what is the cost?","volume":"11","author":"Mannion","year":"2011","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2016.06.007_bib0160","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.spinee.2011.05.010","article-title":"Important considerations on bone morphogenetic protein-2 and neuroinflammation","volume":"11","author":"Heggeness","year":"2011","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2016.06.007_bib0165","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3109\/17453674.2011.636675","article-title":"Improved spinal fusion efficacy by long-term delivery of bone morphogenetic protein-2 in a rabbit model","volume":"82","author":"Lee","year":"2011","journal-title":"Acta Orthop"},{"key":"10.1016\/j.spinee.2016.06.007_bib0170","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.spinee.2009.12.006","article-title":"Biomimetic calcium phosphate coatings as bone morphogenetic protein delivery systems in spinal fusion","volume":"11","author":"Majid","year":"2011","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2016.06.007_bib0175","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/j.1525-1594.2009.00988.x","article-title":"The efficacy of bone morphogenetic protein-2 depends on its mode of delivery","volume":"34","author":"La","year":"2010","journal-title":"Artif Organs"},{"key":"10.1016\/j.spinee.2016.06.007_bib0180","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.spinee.2014.09.021","article-title":"Secreted phosphoprotein 24\u2009kD inhibits nerve root inflammation induced by bone morphogenetic protein-2","volume":"15","author":"Tian","year":"2015","journal-title":"Spine J"},{"key":"10.1016\/j.spinee.2016.06.007_bib0185","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.spinee.2013.06.109","article-title":"Nerve injury and recovery after lateral lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a cohort-controlled study","volume":"14","author":"Lykissas","year":"2014","journal-title":"Spine J"}],"container-title":["The Spine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529943016302406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529943016302406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T22:27:55Z","timestamp":1536618475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1529943016302406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1529943016302406"],"URL":"https:\/\/doi.org\/10.1016\/j.spinee.2016.06.007","relation":{},"ISSN":["1529-9430"],"issn-type":[{"value":"1529-9430","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RhBMP-2-induced radiculitis in patients undergoing transforaminal lumbar interbody fusion: relationship to dose","name":"articletitle","label":"Article Title"},{"value":"The Spine Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.spinee.2016.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}